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ntermediate strains of MRSA. Suscpetibility pattern has also been
tudied to formulate an effective, inexpensive and easily adminis-
ered empirical therapy for GISA and hGISA.
Methods: Three hundred and Forty seven MRSA isolated from
he clinical specimens of Allied hospitals of AMC/NUST and PAEC
eneral Hospital, Pakistan were subjected to the determination of
ancomycin minimum inhibitory concentration (MIC) and isolates
aving vancomycinMIC≥1g/mlwere subjected todetermination
f Glycopeptide resistance detection (GRD) using Etest. Suscepti-
ility pattern of all the isolates were recorded using Kirby baur
isc diffusion method and MIC for linezolid, daptomycin, chloram-
henicol, minocycline and tigecycline using E-strips. MIC 50 and
IC 90 were calculated
Results: All isolates were sensitive to vancomycin but 197 iso-
ates showed higher MICs and 6 turned out to be heterogenous
lycopeptide intermediate (h GISA) strains.
All the isolated organisms were highly susceptible to linezolid
98.3%), daptomycin (100%), chloramphenicol (96%), minocycline
95.7%) and tigecycline (94.8%).
Conclusion: Signiﬁcant number of isolates having MIC of van-
omycin equal to or more than 1 ug/ml have been isolated and
hese can turn out to be GISA/h GISA. Vancomycin Susceptibility
reakpoints as indicated by CLSI should be reevaluated because
hat doesn’t cover GISA/h GISA isolates. This study suggests that
inezolid, chloramphenicol, minocycline, daptomycin and tigecy-
line have high in vitro efﬁcacy for MRSA infections. Prescribing
ntibiotics other than glycopeptides for MRSA infections will min-
mize the chances of emergence of GISA. Good hospital infection
ontrol measures prove to be the main stay against these infec-
ions because antibiotics can never be an effective alternative to
ood medical practice.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.582
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Background: A 57 year old male was seen in the hospital for
ight shoulder septic arthritic with methicillin resistantStaphy-
ococcus aureus(MRSA). He was treated with arthroscopic
ebridement and intravenous vancomycin until susceptibilities
ere available. The minimum inhibitory concentration (MIC) for
ancomycin was 1.5 mcg/ml, therefore the patient was discharged
ome on 6mg/kg of daptomycin once daily to be given for 4 weeks.
he MIC of daptomycin was not checked at that time. Patient
eturned for follow up in 3 weeks and complained of persistent
ever and low back pain. Blood cultures were drawn that grew
RSA again. Spinal imaging revealed lumbar diskiitis. We present
ere a case where ceftaroline was used for treatment along with
ifampin to treat a highly resistant strain of MRSA and the results
f our laboratory tests.fectious Diseases 16S (2012) e317–e473 e421
Methods: Laboratory tests performed on the isolate of MRSA
from blood cultures revealed a high MIC of daptomycin that was
in the resistant range. There was now also a creep noted in the
MIC of vancomycin. The patient’s therapy was changed to ceftaro-
line which resulted in negative blood cultures within 24 hours
of initiating therapy. Serum inhibitory concentration (SIC) and
serum bactericidal concentration (SBC) were performed using the
patient’s serum prior to a dose of ceftaroline after steady state
(trough). Rifampinwas added to therapy after reviewing the results
as shown below in table 1. The SIC and SBC were repeated when he
was treated with a combination of ceftaroline and rifampin.
Results: MIC using E-
tests(mcg/ml)
SIC SBC
Vancomycin 2.0 Not indicated Not indicated
Daptomycin 3.0 Not indicated Not indicated
Ceftaroline 0.38 1:8 dilution 1:16 dilution
Ceftaroline and rifampin – 1:16 dilution Not achieved
Conclusion: Even with the availability of newer antibiotics in
the United States with activity against MRSA, treatment of MRSA
infections (particularly bloodstream infections) can be suboptimal.
Frequent laboratory testing with SIC and SBC may be necessary
even in theabsenceofnegativebloodcultures as apreemptivemea-
sure to detect impending clinical failure. The SIC and SBC results
with the combination of ceftaroline and rifampin suggest antag-
onism between the two antibiotics. Further laboratory tests are
necessary to establish that. This patient was successfully treated
with quinupristin/dalfopristin for 6 weeks.
http://dx.doi.org/10.1016/j.ijid.2012.05.583
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In vitro antimicrobial activity of colistin in combination with
rifampicin against carbapenem-resistant Acinetobacter bau-
mannii
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Background: The in vitro antimicrobial activity of either col-
istin or rifampicin could be increased in the form of combination
between both drugs.
Methods: Thirty carbapenem-resistant A. baumannii isolates
from Bumratnaradoon Hospital between April 2007 and May 2009
were included in this study. Antimicrobial susceptibility tests
were performed by both Kirby-Bauer disk diffusion and Agar dilu-
tion methods. Synergy effect of the combination of colistin and
rifampicin was determined by checkerboard method. In addition,
the time-kill study was used to determine the bactericidal activity
at 0.5×MIC and 1×MIC of either colistin or rifampicin alone and the
combination of both agents. Morphological cell changes of the bac-
teria after growth in the media plus antimicrobials were observed
by using scanning electron microscopy.Results: Susceptibility testing of 12 antimicrobial agents against
carbapenem-resistant A. baumannii showed that all 30 isolates
were resistant to meropenem, imipenem and rifampicin, while
96.7% of these isolates were resistant to cefepime, ceftazidime,
